Literature DB >> 16113176

Naloxone in opioid poisoning: walking the tightrope.

S F J Clarke1, P I Dargan, A L Jones.   

Abstract

Acute opioid intoxication and overdose are common causes of presentation to emergency departments. Although naloxone, a pure opioid antagonist, has been available for many years, there is still confusion over the appropriate dose and route of administration. This article looks at the reasons for this uncertainty and undertakes a literature review from which a treatment algorithm is presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113176      PMCID: PMC1726910          DOI: 10.1136/emj.2003.009613

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  78 in total

1.  Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study.

Authors:  J J Osterwalder
Journal:  J Toxicol Clin Toxicol       Date:  1996

2.  Fatal methadone overdose.

Authors:  T J Hendra; S P Gerrish; A R Forrest
Journal:  BMJ       Date:  1996-08-24

3.  Tramadol overdose requiring prolonged opioid antagonism.

Authors:  D K Sachdeva; B T Jolly
Journal:  Am J Emerg Med       Date:  1997-03       Impact factor: 2.469

4.  Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.

Authors:  K Wanger; L Brough; I Macmillan; J Goulding; I MacPhail; J M Christenson
Journal:  Acad Emerg Med       Date:  1998-04       Impact factor: 3.451

Review 5.  Acute heroin overdose.

Authors:  K A Sporer
Journal:  Ann Intern Med       Date:  1999-04-06       Impact factor: 25.391

6.  Are heroin overdose deaths related to patient release after prehospital treatment with naloxone?

Authors:  G M Vilke; J Buchanan; J V Dunford; T C Chan
Journal:  Prehosp Emerg Care       Date:  1999 Jul-Sep       Impact factor: 3.077

7.  Opioid toxicity recurrence after an initial response to naloxone.

Authors:  W A Watson; M T Steele; R L Muelleman; M D Rush
Journal:  J Toxicol Clin Toxicol       Date:  1998

8.  Patients intoxicated with heroin or heroin mixtures: how long should they be monitored?

Authors:  J J Osterwalder
Journal:  Eur J Emerg Med       Date:  1995-06       Impact factor: 2.799

9.  Out-of-hospital treatment of opioid overdoses in an urban setting.

Authors:  K A Sporer; J Firestone; S M Isaacs
Journal:  Acad Emerg Med       Date:  1996-07       Impact factor: 3.451

Review 10.  A comprehensive review of naloxone for the emergency physician.

Authors:  J M Chamberlain; B L Klein
Journal:  Am J Emerg Med       Date:  1994-11       Impact factor: 2.469

View more
  45 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  A Fentanyl Vaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced Effects in Mice and Rats.

Authors:  Michael D Raleigh; Federico Baruffaldi; Samantha J Peterson; Morgan Le Naour; Theresa M Harmon; Jennifer R Vigliaturo; Paul R Pentel; Marco Pravetoni
Journal:  J Pharmacol Exp Ther       Date:  2018-11-08       Impact factor: 4.030

3.  In Response to: "The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty".

Authors:  Juliana Lombardi; Eric Villeneuve; Sophie Gosselin
Journal:  J Med Toxicol       Date:  2016-10-24

4.  Pharmacokinetics of a new, nasal formulation of naloxone.

Authors:  Ida Tylleskar; Arne Kristian Skulberg; Turid Nilsen; Sissel Skarra; Phatsawee Jansook; Ola Dale
Journal:  Eur J Clin Pharmacol       Date:  2017-01-31       Impact factor: 2.953

5.  Simple minimally-invasive automatic antidote delivery device (A2D2) towards closed-loop reversal of opioid overdose.

Authors:  Bahar Dhowan; Jongcheon Lim; Michael D MacLean; Alycia G Berman; Min Ku Kim; Qi Yang; Jacqueline Linnes; Chi Hwan Lee; Craig J Goergen; Hyowon Lee
Journal:  J Control Release       Date:  2019-05-31       Impact factor: 9.776

6.  Non-cardiogenic pulmonary edema, rhabdomyolysis and myocardial injury following heroin inhalation: a case report.

Authors:  G Bazoukis; A Spiliopoulou; K Mourouzis; P Grigoropoulou; A Yalouris
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

7.  Pharmacokinetics and -dynamics of intramuscular and intranasal naloxone: an explorative study in healthy volunteers.

Authors:  Arne Kristian Skulberg; Ida Tylleskar; Turid Nilsen; Sissel Skarra; Øyvind Salvesen; Trond Sand; Thorsteinn Loftsson; Ola Dale
Journal:  Eur J Clin Pharmacol       Date:  2018-03-22       Impact factor: 2.953

8.  Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts.

Authors:  Steven Allan Sumner; Melissa C Mercado-Crespo; M Bridget Spelke; Leonard Paulozzi; David E Sugerman; Susan D Hillis; Christina Stanley
Journal:  Prehosp Emerg Care       Date:  2015-09-18       Impact factor: 3.077

Review 9.  Management of the critically poisoned patient.

Authors:  Jennifer S Boyle; Laura K Bechtel; Christopher P Holstege
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-06-29       Impact factor: 2.953

10.  Wearable Biosensors to Evaluate Recurrent Opioid Toxicity After Naloxone Administration: A Hilbert Transform Approach.

Authors:  Keerthi Kumar Chintha; Premananda Indic; Brittany Chapman; Edward W Boyer; Stephanie Carreiro
Journal:  Proc Annu Hawaii Int Conf Syst Sci       Date:  2018-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.